ReviewBioactive materials2026
Multifunctional material platforms for neural interfaces: active orchestration of dynamic foreign body response across implantation lifetimes.
Review in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The sustained reliability of invasive brain-computer interface (BCI) electrodes is fundamentally constrained by progressive interface destabilization, a process driven by the dynamic foreign body response (FBR). Given the intricate, time-dependent evolution of the FBR, the establishment of long-term stable neural interfaces necessitates the deployment of sophisticated material architectures capable of intercepting core regulatory mechanisms across distinct pathological phases. This review synthesizes bio-inspired and functional material design strategies, systematically examining their capacity to actively modulate the FBR in a stage-specific manner. Specifically, these approaches are engineered to attenuate acute inflammatory cascades, which is hypothesized to impede detrimental glial scarring-while establishing robust biological barriers resilient to chronic biofouling and infection. Furthermore, by mitigating material degradation and micromotion-induced fretting, these strategies are associated with preserved the functional integrity of the interface over extended periods. By consolidating the theoretical principles, recent advancements, and persisting challenges associated with these material paradigms, this work aims to delineate a forward-looking framework for the development of ultra-durable BCI electrodes, thereby accelerating the clinical translation of neural interface technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.